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Abstract
Melioidosis, a severe infectious disease caused by Burkholderia
pseudomallei that is prevalent in Southeast Asia and Northern
Australia, has been sporadically reported in Brazil since 2003.
We report a case of aortic aneurysm with blood culture positive
for B. pseudomallei. The phylogenetic analysis of 16S ribosomal
DNA showed this isolate to be evolutionarily grouped with the
MSHR346 strains from Thailand.
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Mycotic aneurysm is a localized, irreversible dilatation of an
artery caused by the destruction of the vessel wall by infec-
tion. Most mycotic aneurysms are caused by bacteria, despite
the name, which was coined by Osler to denote their appear-
ance, which is like ‘fresh fungus vegetations’ [1]. Staphylococcus
aureus and serotypes of Salmonella non-typhi are the principal
micro-organisms involved in cases of mycotic aneurysm [2].
The most frequent aetiology of infected aortic aneurysm
appears to be determined by regional conditions and varies
according to a region’s endemic diseases. In a study of infected
aortic aneurysms (80% in men, with average age of 63 years)
in an endemic area for melioidosis, the most common comor-
bidities were hypertension and renal disease. Burkholderia
pseudomallei was the most commonly isolated pathogen
(42.5%) and the abdominal aorta was the most frequently
involved artery (87.5%), followed by the thoracic aorta, com-
mon iliac arteries and superficial femoral arteries [3].
The first description of mycotic aneurysm caused by
B. pseudomallei was published in 1998, from a case of a 70-
year-old man with hypertension admitted to Veterans Gen-
eral Hospital–Kaohsiung, Taiwan, on 25 November 1994 [4].
Since then, B. pseudomallei has been reported as an impor-
tant pathogen in patients suffering from mycotic aneurysm in
endemic regions of Southeast Asia, especially Taiwan, Singa-
pore and Malaysia [5].
Until 2003, melioidosis was generally considered to be
restricted to the region between latitudes 20 North and
20 South. However, in 2003 the first cases were observed
outside this region, in Northeastern Brazil, during a micro-
epidemic in the municipality of Tejuc¸uoca (359¢2000 S
3934¢5000 W) in the state of Ceara´. Since then, isolated
cases and micro-epidemics have been described in various
regions of the state [6].
Here we report a case of aortal aneurysm in a male
patient from Ceara´ state, with blood culture positive for
B. pseudomallei.
On 17 November 2008, a 70-year-old man (a farmer) from
the town of Granja, Ceara´ (307¢1300 S, 4049¢3400 W), was
admitted to an emergency hospital in the region, suffering from
intestinal obstruction. The same day an exploratory laparot-
omy was performed, revealing blood in the abdominal cavity
and aortal aneurysm with blood clots in the aneurysmal sac. A
standard surgical treatment for abdominal aortic aneurysm
that involves replacing the damaged portion of the aorta with
an artificial graft was performed. The blood lost was replaced
and the patient left the surgical room in a stable condition.
After the laparotomy, antimicrobial therapy was started
with sodium cefazolin (1.0 g; intravenously every 8 h), but
the patient’s condition deteriorated, with surgical wound
dehiscence, digestive haemorrhage and sepsis. The antimicro-
bial therapy was changed to cefepime (2 g; intravenously
every 12 h) on 22 November.
On 27 November, the patient was transferred to a gen-
eral hospital run by the state health service located in the
capital, Fortaleza, with worsening of clinical conditions indi-
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cating the need for intensive care. He was placed on an arti-
ficial respirator. The next day he presented mental disorien-
tation and metabolic acidosis. Blood was then drawn for
culture. On 29 November the patient’s condition deterio-
rated further, with arterial hypotension and bradycardia, and
vasopressors were administered. At this time, the antimicro-
bial therapy was changed to piperacillin/tazobactam (4.0 g;
intravenously every 8 h). The next day his clinical condition
worsened, with evidence of septic shock and renal failure.
He died of multiple organ failure.
The result of the blood culture only came back 2 days
after the patient’s death, revealing the presence of B. pseudo-
mallei, identified by VITEK 2 system (biome´rieux, Inc.,
Hazelwond, MO, USA) and PCR. Additionally, phylogenetic
analysis was performed of the 16S region of the nuclear
ribosomal DNA and the evolutionary history was inferred
using the maximum parsimony method [7]. The bootstrap
consensus tree inferred from 100 replicates is taken to rep-
resent the evolutionary history of the taxa analysed [8].
Branches corresponding to partitions reproduced in <50%
bootstrap replicates are collapsed. The percentages of repli-
cate trees in which the associated taxa clustered together in
the bootstrap test (100 replicates) are shown next to the
branches [8]. The maximum parsimony tree was obtained
using the Close-Neighbour-Interchange algorithm [9] with
search level 3 [8,9] in which the initial trees were obtained
with the random addition of sequences (ten replicates). The
codon positions included were 1st + 2nd + 3rd + Non-cod-
ing. All positions containing gaps and missing data were elimi-
nated from the dataset (Complete Deletion option). There
were a total of 1371 positions in the final dataset, out of
which one was parsimony informative. Phylogenetic analyses
were conducted in MEGA4 [10].
Melioidosis is a severe infectious tropical disease associ-
ated with high mortality (septicaemic form), which is preva-
lent in Southeastern Asia and Northern Australia. In Brazil,
the disease and its aetiological agent—an aerobic Gram-nega-
tive bacillus, B. pseudomallei—have been sporadically
reported since 2003 in the Northeast, especially in the state
of Ceara´ [6]. It is normally transmitted through skin wounds
and contact with soil and stagnant water. Burkholderia pseudo-
mallei is an important pathogen in humans and in a wide vari-
ety of animal species in endemic areas, including horses,
sheep, cattle, goats, pigs, cats and dogs [11].
Like many other infectious diseases, melioidosis is also
known for its diverse clinical manifestations, and for many
years in Asia it has been labelled ‘the great mimicker’ in both
the medical literature and the popular press. The most com-
mon clinical manifestations include acute, localized, suppura-
tive skin infection, pulmonary infection and septicaemia [12].
However, melioidosis appearing as a mycotic aortic aneu-
rysm, as described here, has rarely been reported [13].
The aortic aneurysm reported here was diagnosed by
means of an exploratory laparotomy performed at the time
the patient was first hospitalized. Despite the clinical–epide-
miological evidence (farmer with fever and abdominal disten-
sion, residing in an area where melioidosis had been
reported) pointing to melioidosis, with manifestation of
mycotic aneurysm, the involvement of B. pseudomallei was
not considered. After the surgical correction of the abdomi-
nal aortic aneurysm, if the hypothesis of mycotic aneurysm
caused by B. pseudomallei had been considered, the institu-
tion of an empirical antimicrobial therapy would have been a
better treatment regimen. The microbiological diagnosis was
only obtained after the patient’s death, because blood cul-
tures were performed late in the illness.
Diagnosis of mycotic aneurysm is difficult because its inci-
dence is low, even in areas where it is endemic, and the clin-
ical presentation is diverse and may be non-specific. It has
been suggested that diagnosis can be facilitated if it is consid-
ered for febrile patients >40 years of age who reside in or
have ever visited areas where B. pseudomallei is endemic and
who have the following features: (1) abdominal, back or,
more rarely, thigh or chest pain; (2) vertebral, paravertebral
or retroperitoneal collections; (3) confirmed arterial aneu-
rysm; (4) leucocytosis, or (5) no cause identified after initial
investigations [14,15]. The other important clinical scenario
in which the diagnosis should be considered is when results
of blood cultures are recurrently or persistently positive for
B. pseudomallei and no other cause has been identified. In this
situation, computed tomography scanning of the abdomen
with intravenous contrast should be performed, if it is avail-
able. Positive blood culture together with a radiological
abnormality of the artery involved (usually on computed
tomography imaging) strongly suggests bacterial arteritis [16].
Mycotic aortic aneurysm caused by melioidosis remains a
difficult disease to manage. Morbidity and mortality are high
despite correct diagnosis and aggressive surgical and medical
management. It has been proposed that, in endemic areas, the
diagnosis of melioidosis should always be considered for per-
sons with appropriate risk factors suffering from mycotic aneu-
rysm, so that suitable antibiotic therapy can be initiated as
early as possible before surgical intervention. A course of intra-
venous ceftazidime with a minimum duration of 4–6 weeks
should be considered, and maintenance therapy should include
a regimen of two drugs (tromethoprim-sulfamethoxazole and
doxycycline), to reduce the risk of relapse [5].
Melioidosis was first described in the state of Ceara´ only
in 2003 and many members of the local medical community
are still unaware of its clinical manifestations and so of the
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diagnostic and treatment strategies. Because of this, often
B. pseudomallei infection is not suspected and complementary
diagnostic tests are not sought quickly enough, hampering
the administration of antimicrobial therapy.
It has been reported that early diagnosis and aggressive
management of patients with bacterial arteritis is necessary
to ensure better outcome. In endemic countries, B. pseudo-
mallei must always be considered as a possible causative
agent and high-dose intravenous ceftazidime should be
started as soon as possible while awaiting further bacterio-
logical confirmation. Response to treatment is often slow,
and the disease is prone to relapse even after years of appar-
ent quiescence. The antibiotic of choice for acutely septicae-
mic patients is ceftazidime, which is superior to other third-
generation cephalosporins and to a combination of chloram-
phenicol, doxycycline and trimethoprim/sulfamethoxazole
[16]. Ceftazidime therapy is equivalent to therapy with imipe-
nem and intravenous amoxicillin/clavulanate with respect to
mortality rate, but a higher treatment failure rate is associ-
ated with intravenous amoxicillin/clavulanate [17].
The phylogenetic analysis showed that the isolate of
B. pseudomallei from blood was evolutionarily grouped with
the MSHR346, 1106a and 1710b strains of B. pseudomallei, all
originating from Thailand, and was distant from the
B. pseudomallei 668 strains originating from Australia (Fig. 1).
Despite the few reports of aortal aneurysms caused by
B. pseudomallei, in the majority of cases these have occurred
in patients contaminated in endemic regions of Southeast
Asia. Paradoxically, although Australia is also an endemic
zone for melioidosis, no cases of mycotic aneurysm have yet
been reported in this country. Nevertheless, it is known that
strains of B. pseudomallei isolated in the northeast region of
Brazil demonstrate homology of the 16S ribosomal DNA
with Thai strains, which differ from those from Australia.
Our analysis of the 16S ribosomal DNA of the strain from
this patient showed that it is phylogenetically closer to the
Thai strains. Perhaps this homology of strains is related to
the capacity to produce clinical manifestations that are more
similar to those found in Southeast Asia.
In closing, it is important to stress that in cases of mycotic
aneurysm in patients from regions where melioidosis is ende-
mic, particularly Southeast Asia and Northeast Brazil, the
involvement of B. pseudomallei should be investigated
promptly.
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FIG. 1. Evolutionary relationships between B. pseudomallei strain
CEMM 03-6-038 recovered from a case of mycotic aneurysm in
Brazil and strains from Thailand and Australia.
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